GABELLI FUNDS LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 14 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$550,890
-15.6%
750,0000.0%0.00%
-20.0%
Q4 2022$652,410
-1.7%
750,0000.0%0.01%0.0%
Q3 2022$664,000
+2.8%
750,0000.0%0.01%0.0%
Q2 2022$646,000
-2.7%
750,0000.0%0.01%
+25.0%
Q1 2022$664,000
-3.3%
750,0000.0%0.00%0.0%
Q4 2021$687,000
+3.8%
750,0000.0%0.00%0.0%
Q3 2021$662,000
-1.2%
750,0000.0%0.00%0.0%
Q2 2021$670,000
-0.3%
750,0000.0%0.00%
-20.0%
Q1 2021$672,000
+3.2%
750,0000.0%0.01%0.0%
Q4 2020$651,000
+5.3%
750,0000.0%0.01%0.0%
Q3 2020$618,000
+2.0%
750,0000.0%0.01%0.0%
Q2 2020$606,000
+22.9%
750,0000.0%0.01%
+25.0%
Q1 2020$493,000
-8.0%
750,0000.0%0.00%
+33.3%
Q4 2019$536,000
-79.6%
750,000
-80.0%
0.00%
-82.4%
Q3 2019$2,629,000
-18.8%
3,750,000
-21.1%
0.02%
-19.0%
Q2 2019$3,238,0004,750,0000.02%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 20,060,000$22,713,0005.56%
SILVERBACK ASSET MANAGEMENT LLC 7,707,000$6,912,0000.94%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 35,615,000$31,948,0000.74%
DeepCurrents Investment Group LLC 12,521,000$11,079,0000.34%
AGF Investments LLC 4,000,000$3,502,0000.29%
WATER ISLAND CAPITAL LLC 2,250,000$2,014,0000.10%
L & S Advisors Inc 935,000$829,0000.10%
Sculati Wealth Management, LLC 200,000$177,0000.09%
PALISADE CAPITAL MANAGEMENT, LP 3,192,000$2,816,0000.06%
Teton Advisors, Inc. 400,000$354,0000.06%
View complete list of PARATEK PHARMACEUTICALS INC shareholders